These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 15364804)

  • 1. Cardiac specific increase in aldosterone production induces coronary dysfunction in aldosterone synthase-transgenic mice.
    Garnier A; Bendall JK; Fuchs S; Escoubet B; Rochais F; Hoerter J; Nehme J; Ambroisine ML; De Angelis N; Morineau G; d'Estienne P; Fischmeister R; Heymes C; Pinet F; Delcayre C
    Circulation; 2004 Sep; 110(13):1819-25. PubMed ID: 15364804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aldosterone-synthase overexpression in heart: a tool to explore aldosterone's effects.
    Heymes C; Garnier A; Fuchs S; Bendall JK; Nehme J; Ambroisine ML; Robidel E; Swynghedauw B; Milliez P; Delcayre C
    Mol Cell Endocrinol; 2004 Mar; 217(1-2):213-9. PubMed ID: 15134820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NO and PGI(2) in coronary endothelial dysfunction in transgenic mice with dilated cardiomyopathy.
    Drelicharz L; Kozlovski V; Skorka T; Heinze-Paluchowska S; Jasinski A; Gebska A; Guzik T; Olszanecki R; Wojnar L; Mende U; Csanyi G; Chlopicki S
    Basic Res Cardiol; 2008 Sep; 103(5):417-30. PubMed ID: 18431525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aldosterone-induced coronary dysfunction in transgenic mice involves the calcium-activated potassium (BKCa) channels of vascular smooth muscle cells.
    Ambroisine ML; Favre J; Oliviero P; Rodriguez C; Gao J; Thuillez C; Samuel JL; Richard V; Delcayre C
    Circulation; 2007 Nov; 116(21):2435-43. PubMed ID: 17984374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of coronary blood flow during exercise.
    Duncker DJ; Bache RJ
    Physiol Rev; 2008 Jul; 88(3):1009-86. PubMed ID: 18626066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal coronary function in mice deficient in alpha1H T-type Ca2+ channels.
    Chen CC; Lamping KG; Nuno DW; Barresi R; Prouty SJ; Lavoie JL; Cribbs LL; England SK; Sigmund CD; Weiss RM; Williamson RA; Hill JA; Campbell KP
    Science; 2003 Nov; 302(5649):1416-8. PubMed ID: 14631046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistent cardiac aldosterone synthesis in angiotensin II type 1A receptor-knockout mice after myocardial infarction.
    Katada J; Meguro T; Saito H; Ohashi A; Anzai T; Ogawa S; Yoshikawa T
    Circulation; 2005 May; 111(17):2157-64. PubMed ID: 15851599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronary vascular effects of vasoactive intestinal peptide in the isolated perfused rat heart.
    Sawmiller DR; Henning RJ; Cuevas J; Dehaven WI; Vesely DL
    Neuropeptides; 2004 Oct; 38(5):289-97. PubMed ID: 15464194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of ischaemic preconditioning in the eNOS overexpressed working mouse heart model.
    du Toit EF; Genade S; Carlini S; Moolman JA; Brunner F; Lochner A
    Eur J Pharmacol; 2007 Feb; 556(1-3):115-20. PubMed ID: 17157294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor necrosis factor-alpha induces endothelial dysfunction in the prediabetic metabolic syndrome.
    Picchi A; Gao X; Belmadani S; Potter BJ; Focardi M; Chilian WM; Zhang C
    Circ Res; 2006 Jul; 99(1):69-77. PubMed ID: 16741160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TNF-alpha contributes to endothelial dysfunction by upregulating arginase in ischemia/reperfusion injury.
    Gao X; Xu X; Belmadani S; Park Y; Tang Z; Feldman AM; Chilian WM; Zhang C
    Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1269-75. PubMed ID: 17413034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transgenic expression of fatty acid transport protein 1 in the heart causes lipotoxic cardiomyopathy.
    Chiu HC; Kovacs A; Blanton RM; Han X; Courtois M; Weinheimer CJ; Yamada KA; Brunet S; Xu H; Nerbonne JM; Welch MJ; Fettig NM; Sharp TL; Sambandam N; Olson KM; Ory DS; Schaffer JE
    Circ Res; 2005 Feb; 96(2):225-33. PubMed ID: 15618539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transgenic myocardial overexpression of prokineticin receptor-2 (GPR73b) induces hypertrophy and capillary vessel leakage.
    Urayama K; Dedeoglu DB; Guilini C; Frantz S; Ertl G; Messaddeq N; Nebigil CG
    Cardiovasc Res; 2009 Jan; 81(1):28-37. PubMed ID: 18806277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of peripheral endothelial dysfunction by protein tyrosine phosphatase inhibitors in heart failure.
    Vercauteren M; Remy E; Devaux C; Dautreaux B; Henry JP; Bauer F; Mulder P; Hooft van Huijsduijnen R; Bombrun A; Thuillez C; Richard V
    Circulation; 2006 Dec; 114(23):2498-507. PubMed ID: 17101854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aldosterone causes vasoconstriction in coronary arterioles of rats via angiotensin II type-1 receptor: influence of hypertension.
    Kushibiki M; Yamada M; Oikawa K; Tomita H; Osanai T; Okumura K
    Eur J Pharmacol; 2007 Oct; 572(2-3):182-8. PubMed ID: 17644087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutation of the circadian clock gene Per2 alters vascular endothelial function.
    Viswambharan H; Carvas JM; Antic V; Marecic A; Jud C; Zaugg CE; Ming XF; Montani JP; Albrecht U; Yang Z
    Circulation; 2007 Apr; 115(16):2188-95. PubMed ID: 17404161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinin B1 receptor participates in the control of cardiac function in mice.
    Lauton-Santos S; Guatimosim S; Castro CH; Oliveira FA; Almeida AP; Dias-Peixoto MF; Gomes MA; Pessoa P; Pesquero JL; Pesquero JB; Bader M; Cruz JS
    Life Sci; 2007 Aug; 81(10):814-22. PubMed ID: 17714737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced cardiac function in mice overexpressing protein phosphatase Inhibitor-2.
    Kirchhefer U; Baba HA; Bokník P; Breeden KM; Mavila N; Brüchert N; Justus I; Matus M; Schmitz W; Depaoli-Roach AA; Neumann J
    Cardiovasc Res; 2005 Oct; 68(1):98-108. PubMed ID: 15975567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of nitric oxide-producing and -degrading pathways in coronary endothelial dysfunction in chronic kidney disease.
    Tatematsu S; Wakino S; Kanda T; Homma K; Yoshioka K; Hasegawa K; Sugano N; Kimoto M; Saruta T; Hayashi K
    J Am Soc Nephrol; 2007 Mar; 18(3):741-9. PubMed ID: 17267746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiomyocyte-specific overexpression of nitric oxide synthase 3 prevents myocardial dysfunction in murine models of septic shock.
    Ichinose F; Buys ES; Neilan TG; Furutani EM; Morgan JG; Jassal DS; Graveline AR; Searles RJ; Lim CC; Kaneki M; Picard MH; Scherrer-Crosbie M; Janssens S; Liao R; Bloch KD
    Circ Res; 2007 Jan; 100(1):130-9. PubMed ID: 17138944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.